It was the hot place to work from 2010-early 2013. Big layoffs came in November 2013 and a shaky future and revolving door since then. CF has been approved and expanded, but its a shaky future. Lots of takeover rumors. Too much reliance on rare disease pricing in a new political age of both political parties calling for price controls and medicare negotiation.